Načítá se...
Use, tolerability and compliance of spironolactone in the treatment of heart failure
BACKGROUND: Risk of morbidity and mortality in patients with severe heart failure (HF) is reduced by blockade of aldosterone receptors with spironolactone. However, benefits of spironolactone are potentially limited by treatment compliance and adverse events profile. The aim of this study was to est...
Uloženo v:
| Hlavní autoři: | , , |
|---|---|
| Médium: | Artigo |
| Jazyk: | Inglês |
| Vydáno: |
BioMed Central
2011
|
| Témata: | |
| On-line přístup: | https://ncbi.nlm.nih.gov/pmc/articles/PMC3121672/ https://ncbi.nlm.nih.gov/pubmed/21599961 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/1472-6904-11-4 |
| Tagy: |
Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!
|